Anna Cleland-Leighton
Family Medicine · Hiawatha, KSNPI 1891280186
Payments from drug & device makers
Across 94 payments — averaging $17.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$316
- Lilly USA, LLC$218
- AstraZeneca$154
- Boehringer Ingelheim$147
- Amgen$124
- Novo Nordisk$106
- plus $546 from 18 others
What the payments were for
- Food & beverage$1,610100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $316 |
| Lilly USA, LLC | 10 | $218 |
| AstraZeneca | 11 | $154 |
| Boehringer Ingelheim | 9 | $147 |
| Amgen | 8 | $124 |
| Novo Nordisk | 7 | $106 |
| Novartis | 6 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| GSK | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $32 |
| Johnson & Johnson | 2 | $30 |
| Lundbeck LLC | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Pfizer | 2 | $28 |
| Alkermes, Inc. | 1 | $27 |
| KCI USA, Inc. | 1 | $26 |
| Philips North America LLC | 1 | $22 |
| Dexcom, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Abbott | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Viatris Specialty LLC | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
How this compares
$1,610 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 40 | $40,501 |
| MounjaroTirzepatide | 26 | $34,271 |
| EliquisApixaban | 54 | $33,482 |
| OzempicSemaglutide | 28 | $27,902 |
| TrulicityDulaglutide | 16 | $23,170 |
| Bydureon BciseExenatide Microspheres | 18 | $15,752 |
| JardianceEmpagliflozin | 12 | $13,545 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 20 | $11,361 |
| Spiriva HandihalerTiotropium Bromide | 17 | $10,915 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $10,190 |
| DapagliflozinDapagliflozin Propanediol | 13 | $7,140 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $6,874 |
| Varenicline Tartrate | 15 | $5,103 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $2,431 |
| Roflumilast | 11 | $2,177 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $218 | $57,44142 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $154 | $47,37452 claims |
| PfizerEliquis | $28 | $33,48254 claims |
| Novo NordiskOzempic | $106 | $27,90228 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $147 | $24,90732 claims |
| GSKTrelegy Ellipta | $35 | $10,19015 claims |
| AbbVieCreon | $316 | $2,07111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Hiawatha
- Terry PolingWichita$24.2M
- Richard GloverNewton$19.6M
- Daniel DickersonLenexa$13.6M
- Patrick YaoOlathe$11.7M
- Michael RauschAugusta$8.1M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
- Thomas KleinWichita$3.4M
- Troy HoldemanNewton$3.2M
- Stacy SlechtaNewton$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.